Tissue is the issue and tissue competition. Re-biopsy for mutation T790: where and why?

Lung cancer is still the leading cause of death among all cancers. During the last 15  years, pharmacogenomics of lung cancer have established targeted therapy with tyrosine kinase inhibitors (TKIs) for epiderm...

Source: Clinical and Translational Medicine - January 18, 2017 Category: Internal Medicine Authors: Paul Zarogoulidis, Mina Gaga, Haidong Huang, Kaid Darwiche, Aggeliki Rapti and Wolfgang Hohenforst-Schmidt Source Type: research